GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 2010-2014  (1)
  • Latin America, Caribbean and Latino Studies  (1)
Material
Publisher
Language
Years
  • 2010-2014  (1)
Year
FID
  • Latin America, Caribbean and Latino Studies  (1)
  • 1
    In: Ciência & Saúde Coletiva, FapUNIFESP (SciELO), Vol. 18, No. 7 ( 2013-07), p. 1903-1910
    Abstract: End-stage renal disease (ESRD) is a serious public health problem. The study of the impact of renal replacement therapy (RRT) in quality of life (QoL) has become increasingly important. The aim of this study was to evaluate the QoL of patients on RRT and associated factors. 3036 patients on RRT in Brazil were interviewed in relation to socioeconomic, demographic, clinical and QoL aspects. Patients were randomly selected after a cluster sampling process on two levels: health services and patients. QoL was measured by Eq5D. The instrument allows the indirect measurement of QoL and utility calculation, in addition to the direct measurement of QoL by a visual analog scale (VAS). It was observed that transplant patients have better QoL and that the most prejudicial aspects are pain/discomfort and anxiety/depression. The main factors associated with QOL are age, female gender, variables associated with the clinical condition of the patient such as the need for hospitalization and the presence of comorbidities, social class and variables associated with the health service use. The correlation between VAS and utility calculated was moderate and the 5 Eq5D questions explain 43% of the variability of VAS. The calculated utility can be used in cost-utility analysis.
    Type of Medium: Online Resource
    ISSN: 1413-8123
    Language: Unknown
    Publisher: FapUNIFESP (SciELO)
    Publication Date: 2013
    detail.hit.zdb_id: 2078799-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...